FlexPro MD® (Collagen, Hyaluronic Acid and Boswellia Joint Blend)

FlexPro MD® is a joint-health blend that combines low-molecular-weight collagen peptides, hyaluronic acid, and Boswellia serrata extract. The three ingredients target joint comfort, lubrication, and inflammation together, and the combination has been tested in a multicenter, randomized, placebo-controlled trial.

FlexPro MD is researched primarily for Joint Health. In a multicenter randomized controlled trial, the collagen, hyaluronic acid, and boswellia blend supported reductions in joint discomfort and better joint function.

The clinically studied dose is One daily serving of the combined blend. Always follow the product label and check with a healthcare provider for personal advice.

For most healthy adults, FlexPro MD is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — adverse events in the trial were minimal. Mild digestive upset is occasionally reported. It may also interact with some medications. FlexPro MD is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Possible interactions include: Anticoagulants — boswellia may have a mild additive effect; monitor. Anti-inflammatory drugs — additive effect possible. If you take prescription medication, check with a pharmacist or doctor before using it.

NutraSmarts rates the evidence for FlexPro MD as Moderate (3 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.